Stephen S. Roberts

5.1k total citations · 1 hit paper
73 papers, 1.3k citations indexed

About

Stephen S. Roberts is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Stephen S. Roberts has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Neurology, 24 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Stephen S. Roberts's work include Neuroblastoma Research and Treatments (46 papers), Cancer, Hypoxia, and Metabolism (17 papers) and Cancer therapeutics and mechanisms (16 papers). Stephen S. Roberts is often cited by papers focused on Neuroblastoma Research and Treatments (46 papers), Cancer, Hypoxia, and Metabolism (17 papers) and Cancer therapeutics and mechanisms (16 papers). Stephen S. Roberts collaborates with scholars based in United States, Belgium and France. Stephen S. Roberts's co-authors include Nai‐Kong V. Cheung, Ellen M. Basu, Shakeel Modak, Brian H. Kushner, Irene Y. Cheung, Kim Kramer, Alexander J. Chou, Neerav Shukla, Michael V. Ortiz and Arlene Naranjo and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and PEDIATRICS.

In The Last Decade

Stephen S. Roberts

67 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

2019 214 citations Stephen S. Roberts et al. profile →

Peers

Countries citing papers authored by Stephen S. Roberts

Since Specialization

Citations

This map shows the geographic impact of Stephen S. Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen S. Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen S. Roberts more than expected).

Fields of papers citing papers by Stephen S. Roberts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen S. Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen S. Roberts. The network helps show where Stephen S. Roberts may publish in the future.

Co-authorship network of co-authors of Stephen S. Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen S. Roberts. A scholar is included among the top collaborators of Stephen S. Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen S. Roberts. Stephen S. Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission 2025 ·Clinical Cancer Research ·Brian H. Kushner, Shakeel Modak, Audrey Mauguen, Ellen M. Basu, Kim Kramer, Stephen S. Roberts, Irene Y. Cheung, Nai‐Kong V. Cheung	1
2	Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults 2023 ·JCO Precision Oncology ·(unknown), Brian H. Kushner, Stephen S. Roberts, (unknown), Kim Kramer, Shakeel Modak	4
3	Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma 2023 ·iScience ·(unknown), Yujie Fan, (unknown), Celine Everaert, Wouter Van Loocke, (unknown), (unknown), (unknown), (unknown), Vanessa Vermeirssen, Katleen De Preter, Ting Zhou, Alex Kentsis, Lorenz Studer, Frank Speleman, Stephen S. Roberts	2
4	Chemotherapy‐induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention 2022 ·Pediatric Blood & Cancer ·(unknown), Katherine Armstrong, Audrey Mauguen, Emily K. Slotkin, Stephen S. Roberts, Ira J. Dunkel, Mary C. Clouser, Michael V. Ortiz, Gerald A. Soff	3
5	v‐SYMPHONY career development series: A collaboration to enhance professional awareness for pediatric hematology oncology trainees 2022 ·Pediatric Blood & Cancer ·(unknown), Kayleen Bailey, Alexander J. Chou, Katharine Offer, Jeremy Rosenblum, (unknown), (unknown), Stephen S. Roberts, (unknown), Andrea D. Orsey, Gabriel Robbins, Prakash Satwani, Joanna Pierro, Jennifer Levine	1
6	From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma 2021 ·Journal of Personalized Medicine ·Bieke Decaesteker, Kaat Durinck, Nadine Van Roy, Bram De Wilde, Christophe Van Neste, (unknown), Stephen S. Roberts, Katleen De Preter, Vanessa Vermeirssen, Frank Speleman	2
7	Translational Strategies for Repotrectinib in Neuroblastoma 2021 ·Molecular Cancer Therapeutics ·(unknown), Glorymar Ibáñez, (unknown), Audrey Mauguen, (unknown), Néstor Rosales, (unknown), (unknown), Daoqi You, (unknown), Stephen S. Roberts, Andrew L. Kung, Filemon S. Dela Cruz	8
8	COVID‐19 has changed the way we think about training future pediatric hematologists/oncologists 2021 ·Pediatric Blood & Cancer ·(unknown), (unknown), Jennifer Levine, Alexander J. Chou, (unknown), Jennifer A. Oberg, Joanna Pierro, Stephen S. Roberts, Prakash Satwani	4
9	Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN‐amplified neuroblastoma 2021 ·Pediatric Blood & Cancer ·(unknown), Brian H. Kushner, Shakeel Modak, Ellen M. Basu, Elyssa Rubin, Gunes Gundem, Elli Papaemmanuil, Stephen S. Roberts	8
10	Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes 2019 ·Scientific Reports ·Dries Rombaut, Hua‐Sheng Chiu, Bieke Decaesteker, Celine Everaert, Nurten Yigit, Agathe Peltier, Isabelle Janoueix‐Lerosey, Christoph Bartenhagen, Matthias Fischer, Stephen S. Roberts, Nicky D’Haene, Katleen De Preter, Frank Speleman, Geertrui Denecker, Pavel Sumazin, Jo Vandesompele, Steve Lefever, Pieter Mestdagh	10
11	Local Anesthesia With General Anesthesia for Pediatric Bone Marrow Procedures 2019 ·PEDIATRICS ·(unknown), (unknown), Melissa Mathias, (unknown), (unknown), (unknown), Michael V. Ortiz, Kay See Tan, Michael Kellick, Shakeel Modak, Stephen S. Roberts, Ellen M. Basu, (unknown)	3
12	Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors 2019 ·Frontiers in Oncology ·Michael V. Ortiz, Stephen S. Roberts, Julia Glade Bender, Neerav Shukla, Leonard H. Wexler	53
13	Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Dana L. Casey, Brian H. Kushner, Nai‐Kong V. Cheung, Shakeel Modak, Ellen M. Basu, Stephen S. Roberts, Michael P. LaQuaglia, Suzanne L. Wolden	14
14	Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study 2018 ·OncoImmunology ·Shakeel Modak, Jean-Benoît Le Luduec, Irene Y. Cheung, Debra A. Goldman, Irina Ostrovnaya, Ekaterina Doubrovina, Ellen M. Basu, Brian H. Kushner, Kim Kramer, Stephen S. Roberts, Richard J. O’Reilly, Nai‐Kong V. Cheung, Katharine C. Hsu	70
15	Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival 2017 ·OncoImmunology ·Irene Y. Cheung, Brian H. Kushner, Shakeel Modak, Ellen M. Basu, Stephen S. Roberts, Nai‐Kong V. Cheung	28
16	Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines 2010 ·Translational Oncology ·(unknown), Karen Wolcott, Stephen S. Roberts	18
17	Methicillin-ResistantStaphylococcus aureusInfections in U.S. Service Members Deployed to Iraq 2009 ·Military Medicine ·Stephen S. Roberts, (unknown)	18
18	Unique Management of Stage 4S Neuroblastoma Complicated by Massive Hepatomegaly: Case Report and Review of the Literature 2002 ·The American journal of pediatric hematology/oncology ·Stephen S. Roberts, Kevin M. Creamer, (unknown), (unknown), Daniel K. Robie	13
19	An Indicator of Informal Empire: Patterns of U.S. Navy Cruising on Overseas Stations, 1869-1897. 1980 ·Defense Technical Information Center (DTIC) ·Stephen S. Roberts	2
20	Task Management for Firefighters: A Practical Approach to Task Management. 1979 ·Stephen S. Roberts	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact